Acute disseminated encephalomyelitis natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Acute disseminated encephalomyelitis}} | {{Acute disseminated encephalomyelitis}} | ||
{{CMG}}; {{AE}} {{Sujaya}} | {{CMG}}; {{AE}} {{Sujaya}} | ||
==Overview== | ==Overview== | ||
Revision as of 06:51, 15 November 2022
Acute disseminated encephalomyelitis Microchapters |
Differentiating Acute disseminated encephalomyelitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute disseminated encephalomyelitis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Acute disseminated encephalomyelitis natural history, complications and prognosis |
FDA on Acute disseminated encephalomyelitis natural history, complications and prognosis |
CDC on Acute disseminated encephalomyelitis natural history, complications and prognosis |
Acute disseminated encephalomyelitis natural history, complications and prognosis in the news |
Blogs on Acute disseminated encephalomyelitis natural history, complications and prognosis |
Directions to Hospitals Treating Acute disseminated encephalomyelitis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]